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Abstract Many efforts have been made to produce artificial
materials with biomimetic properties for applications in bind-
ing assays. Among these efforts, the technique of molecular
imprinting has received much attention because of the high
selectivity obtainable for molecules of interest, robustness of
the produced polymers, simple and short synthesis, and excel-
lent cost efficiency. In this review, progress in the field of
molecularly imprinted sorbent assays is discussed—with a
focus on work conducted from 2005 to date.
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Introduction
Specific receptor–ligand interactions are a fundamental pro-
cess in biological systems, essential for the generation of
physiological responses to substances such as hormones, pro-
teins, cellular markers, antigens etc. The specific nature of
biological recognition, in particular of antibodies and en-
zymes, has led to their exploitation as the recognition element
of choice in many assay systems and biosensors. However,
despite possessing high specificity and sensitivity for their
respective ligands, biomolecules suffer the disadvantages of
fragility and high cost. The ability to mimic the highly specific
nature of antibodies and enzymes in more robust and lower
cost materials has been of great interest to researchers in the
field. Consequently, much effort has been expended in the
design and synthesis of artificial materials with biomimetic
properties. Among these, the technique of molecular imprint-
ing has receivedmuch attention because of the high selectivity
obtainable for molecules of interest. Coupled with the advan-
tages of short synthesis time, robustness, regeneration (and
consequently cost efficiency), as well as cheap initial produc-
tion, molecularly imprinted polymers (MIPs) provide an at-
tractive alternative to conventional biological receptors.
The process of molecular imprinting involves the synthesis
of a polymericmaterial in the presence of a template, producing
complementary recognition sites in the imprinted polymer that
are specific for the template molecule (Fig. 1). This is achieved
by addition of the template to a polymerization mixture com-
prising functional monomer, cross-linking agent, and solvent
(sometimes referred to as the porogen). A prepolymerization
complex is initially formed, with functional monomers arrang-
ing themselves around the template in a manner influenced by
the shape and chemical properties of the template. Subsequent
polymerization of this complex fixes the monomers in this
arrangement, and removal of the template affords a comple-
mentary recognition site for the template molecule. In this way,
an imprinted polymer is constructed with molecular memory
for the substrate of interest by a self-assembly process [1–6].
The development of molecularly imprinted sorbent
assays, a brief history
Once imprinted polymers could be generated with affinity and
selectivity comparable to biological antibodies, the potential
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to compete as a genuine synthetic alternative in assays became
possible. In 1993, Vlatakis et al. described such an assay,
coining the term Bmolecularly imprinted [sorbet] assay^
(MIA) [7]. Imprinted polymers of ethylene dimethacrylate-
co-methacrylic acid were prepared by bulk polymerization
against two chemically unrelated drugs, theophylline (a bron-
chodilator) and diazepam (a tranquilizer). TheMIPs were suc-
cessfully employed in assays analogous to competitive
radiolabeled immunoassays, achieving impressive results:
for theophylline, measurements were linear over the range of
14–224 μM, the results of analysis of serum samples from 32
patients showed excellent correlation with those obtained
using the enzyme-multiplied immunoassay technique
(EMIT), and cross-reactivity against other major metabolites
and structurally similar compounds was shown to be similar to
that observed with biological antibodies. Whilst these results
were encouraging, the MIA method was more cumbersome
than EMIT as a consequence of the necessary extraction of
analyte from the biological sample prior to analysis, due to the
polymers giving optimal binding and selectivity only in or-
ganic solvents.
Molecular imprinting of morphine and the endogenous
neuropeptide [Leu5]-enkephalin in methacrylic acid-ethylene
glycol dimethacrylate copolymers and their application to a
similar radioactive ligand binding assay were described by
Andersson et al. in 1995 [8]. These MIPs demonstrated high
binding affinity and selectivity in aqueous buffers as well as
organic solvents, presenting a major breakthrough for molec-
ular imprinting technology since the binding reactions were
now occurring under conditions relevant to biological sys-
tems. Although efficient rebinding was possible in aqueous
buffers, the affinities and selectivities obtained were lower
than those obtained in the best organic solvents.
The influence of parameters affecting ligand binding in
water were subject to further study, and an optimization of
the assay conditions for (S)-propranolol afforded similarly
high sensitivity under both organic and aqueous conditions,
with limits of detection (LoD) as low as 5.5 and 6.0 nM,
respectively [9]. This represented a 100- to 1000-fold im-
provement compared to LoDs previously achieved with
MIPs, placing both aqueous and organic solvent-based
MIAs on the same level as immunoassays using biological
antibodies.
Having developed analyte-MIP systems that may be uti-
lized equally well using an aqueous buffer or an organic sol-
vent, progression into direct assay of biological samples was
next to be reported. Using (S)-propranolol MIPs prepared in
the same manner as the aforementioned study, a radiolabeled
assay for direct determination of the concentration of (S)-pro-
pranolol in human plasma and urine was accomplished over
the range 20 to 1000 nM with accuracies of 89 %-107 % and
91 %-125 %, respectively [10]. These results demonstrated
that it was possible to carry out molecular imprint-based as-
says of biological samples without prior sample clean up.
Whilst attempting to develop a detection system for the
herbicide 2,4-dichlorophenoxyacetic acid (2,4-D), Haupt
et al., following limited success imprinting in the presence
of nonpolar solvents, investigated whether specific
noncovalent molecular imprints could be obtained in the pres-
ence of polar solvents using a combination of the hydrophobic
effect and ionic interactions [11]. The template, 2,4-D func-
tioned well in this role owing to its hydrophobic aromatic ring
Fig. 1 Schematic representation of the molecular imprinting process [1].
Reproduced with permission from: Molecular Imprinting Science and
Technology: a survey of the literature for the years up to and including
2003, Alexander C et al. Journal of Molecular Recognition, Vol. 19:2,
Copyright © 2003, John Wiley and Sons
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and ionisable carboxyl group. Polymers synthesized using 4-
vinylpyridine as functional monomer and ethylene glycol
dimethacrylate as cross-linker demonstrated an appreciable
binding specificity and sensitivity comparable to indirect
enzyme-linked immunosorbent assay (ELISA) or radioimmu-
noassay (RIA). These findings extended the potential applica-
bility of noncovalent molecular imprinting to assays in cases
where either the use of polar solvents may be required, or the
target molecule may lack the functionality required for im-
printing in nonpolar solvents.
Despite the undeniable advantage provided by the possibil-
ity of using radiolabeled tracers with identical chemical struc-
ture to the analyte of interest, issues concerning the commer-
cial unavailability of isotopic-labeled tracers for many com-
pounds of interest coupled with apprehensions over the han-
dling and disposal of radionuclides made the development of
assays based on other labeling and detection methods an at-
tractive proposition. The first MIA to remove the necessity for
radiolabeling was developed by Piletsky et al., who utilized
competition between a fluorescein-labeled triazine analogue
and unlabeled triazine for specific binding sites in an
imprinted polymer to achieve an optical sensor based on fluo-
rescence measurement [12]. This assay exhibited sensitivity
for triazine over the range 0.01–100 mM, demonstrating that
highly sensitive optical assays based on safe fluorescent labels
could offer a promising alternative to the currently adopted
radiolabeling approach.
An alternative approach to utilize changes in fluorescence
as the detection mechanism led to the design of a fluorescent
functional monomer: trans-4-[p-(N,N-dimethylamino)styryl]-
N-vinylbenzenepyridinium chloride [13]. Thismonomer com-
bined microenvironmental sensitive fluorescence, attributable
to intramolecular charge-transfer behavior, with a positive
charge capable of association with negatively charged nucle-
otides, together with a vinyl group, necessary for incorpora-
tion into the polymer matrix. With these characteristics, the
monomer was incorporated within a methacrylate polymer,
where it acted as both the recognition and detection element
for the fluorescence determination of adenosine 3′:5′-cyclic
monophosphate (cAMP) in aqueous media. The binding of
cAMP led to a quantifiable quenching of fluorescence, where-
as almost no effect was observed in the presence of the struc-
turally similar molecule guanosine 3′5′-cyclic monophosphate
(cGMP). Whilst this demonstrated the utility of modifying the
MIP rather than analyte in order to elicit a response to binding,
the use of fluorophores, which act simultaneously as both
recognition element and detection element means that new
monomers will need to be specifically designed for each class
of analyte.
Another substitute for radiolabeling commonly employed
in immunoassays involves the incorporation of enzyme labels;
however, these initially seemed less suitable in MIAs for two
reasons. First, enzymes often only work in aqueous buffers,
and second, the hydrophobic nature and highly cross-linked
structure of the polymers was proposed to limit the access of
large protein molecules to the imprinted sites. As previously
discussed, MIPs that perform well in aqueous solvents had
been developed; however, the second problem of binding site
accessibility required the development of new synthesis
methods such as the preparation of monodisperse spherical
imprinted polymer particles in the submicron-size range via
precipitation polymerization. Ye et al. developed the synthesis
of particles imprinted with theophylline and 17β-estradiol and
demonstrated radioligand binding assays for the two analytes
[14]. The imprinted microspheres demonstrated higher bind-
ing site densities and more rapid kinetics as a direct conse-
quence of their small diameter. The potential use of molecu-
larly imprinted microspheres in ELISA-like assays was tested
by Surugiu et al. for the herbicide 2,4-D and using the enzyme
label tobacco peroxidase as a conjugate tracer for colorimetric
and chemiluminescence detection, with calibration curves ob-
tained ranging over 40–600 μg mL−1 and 1–200 μg mL−1,
respectively [15]. Even though this assay was still less sensi-
tive than some antibody-based assays, the findings showed for
the first time that imprinted polymers could be compatible
with enzyme labels, broadening the potential for the applica-
tion of MIPs in immunoassay-type applications. Identifying
the ever-increasing demand for automated, high-throughput
assaying and screening of natural products, as well as of bio-
logical and chemical combinatorial libraries, the same group
decided to adapt their ELISA-type MIP-based imaging assay
for this purpose [16]. Microtiter plates (96 or 384 wells) were
coated with polymer microspheres imprinted with 2,4-D,
which were fixed in place using poly(vinyl alcohol) as glue.
Using a competitive format, the amount of polymer-bound 2,
4-D-peroxidase conjugate was quantified using luminol as the
chemiluminescent substrate. Light emission was consequently
measured in a high-throughput imaging format with a CCD
camera-based imaging system, allowing simultaneous mea-
surement of a large number of samples. The detection limit
of 2,4-D in this assay was 34 nM, with a useful range from 68
nM to 680 μM—a dynamic range only slightly narrower than
that reported for antibody-based assays (although the
antibody-based assays did have lower detection limits).
Further optimization for high throughput screening pur-
poses led to a novel assay aimed at eliminating the require-
ment for a separation step prior to quantification of the target
analyte, in order to greatly increase sample throughput [17].
Generation of the binding signal was based on the principle of
proximity scintillation between a scintillation fluor covalently
incorporated into the MIP microparticles during preparation
and the tritium-labeled analyte. Following radiolabeled ligand
binding, the scintillation fluor converts incident β-radiation
into a fluorescent signal, removing any need for separation
of bound and unbound analyte prior to signal quantification
(Fig. 2). Although this was the first demonstration of a
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homogenous MIP assay, the use of radiolabeled tracers was a
step back from recent advances, where their usage was largely
replaced by that of fluorescent and enzymatic tracers for rea-
sons previously discussed.
Recent developments in MIP-based assays
Of the MIAs developed since the initial work of Vlatakis
et al., the majority can be classified into one of three
categories determined by the type of label used for sig-
naling: radio-labeling, fluorescence-labeling, or enzyme-
linked. Recent years have seen the emergence of numer-
ous novel assay types that do not fall into these catego-
ries; however, as each is seemingly unique in its ap-
proach, these have been grouped simply as Bothers^ for
simplicity. As the focus of this review is on recent ad-
vances, only assays reported from 2005 onwards have
been included; however numerous excellent reviews cov-
ering developments made in the preceding years are
available [18–27].
Radio-labeled MIAs
A series of significant breakthroughs in MIP technology came
as a result of novel synthetic methods to generate spherical,
molecularly imprinted beads as an alternative to conventional
MIP particles produced through bulk polymerization followed
by grinding into small particles. Various approaches were de-
veloped, such as dispersion polymerization [28], suspension
polymerization [29–31], activated swelling and thermal poly-
merization [32], precipitation polymerization [33–49], distil-
lation precipitation polymerization [50, 51], core-shell poly-
merization [52–58], surface grafting methods [59–63],
Pickering emulsion polymerization [64–66], hierarchical im-
printing in porous silica [67, 68], and mini-emulsion polymer-
ization [69], allowing for a diverse number of strategies for
generating regular sized beads with narrow size distributions
for different applications. Some of these methods have been
reviewed by Pérez-Moral and Mayes [70]. Numerous investi-
gations were thus carried out in order to assess the potential
advantages of these new MIP formats in MIAs, with most
being initially tested through incorporation into radio-labeled
MIAs.
Based on previous work on polymerization precipitation,
the group of Wei et al. reported an optimization of the tech-
nique for the preparation of 17β-estradiol imprinted nano-
spheres for use in radio-labeledMIAs [71]. This work focused
on accurate control and optimization of the governing param-
eters for precipitation polymerization, taking into consider-
ation the nature of the cross-linker, the monomer concentra-
tions, and the polymerization temperature, and their conse-
quent effects on the imprinted nanospheres generated. From
these investigations, 17β-estradiol imprinted beads of 400 nm
diameter were used in the development of a competitive bind-
ing assay, which showed a linear detection range from 0.01 to
1000 μg mL−1 with significant stereoselectivity for 17β-
estradiol over its α-epimer.
Similar studies were performed by Ye et al., who success-
fully synthesized (R,S)-propranolol imprinted spherical nano-
particles of 130 nm with uniform size distribution by modify-
ing the conditions of precipitation polymerization [72].
Through varying the composition of the cross-linker it was
found that the particle size could be reasonably controlled
over the range 130 nm to 2.4 μm, whilst the favorable binding
properties remained intact. This led to the development of a
highly enantioselective competitive radioligand binding assay,
where the small MIP nanoparticles exhibited 20 times affinity
for (S)-propranolol over the (R)-enantiomer, demonstrating a
six- to sevenfold increase over previously reported irregular
particles.
Aside from precipitation polymerization, Kempe and
Kempe reported modifications on suspension polymerization
in mineral oil for the preparation of (R,S)-propranolol
imprinted microspheres [73]. The one-step synthesis avoided
Fig. 2 Schematic representation of chemical sensing with an imprinted
polymer through proximity scintillation [18]. The polymerizable fluor
(1a) is incorporated into imprinted particles with affinity for the
template, naproxen (2). The fluor emits light in response to β-decay of
tritium-labeled naproxen, but not other labeled analytes (a); competition
between radiolabeled naproxen and free (unlabeled naproxen) (b) can be
used to quantify the analyte without separation of the bound and free
components. Reprinted with permission from Ye L, Mosbach K (2001)
Journal of the American Chemical Society 123(12):2901–2902
Copyright 2001 American Chemical Society
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the use of water and stabilizer/surfactant, which had been a
criticism of other techniques because of interference with hy-
drogen bonds effecting template–monomer complex forma-
tion during noncovalent imprinting. The size of beads synthe-
sized was controllable over the range 1–100 μm, which were
obtained in almost quantitative yield, with higher binding ca-
pacities observed in comparison to MIP particles prepared
through bulk polymerization, likely due to better accessibility
of binding sites in the spherical beads. The MIP microbeads
were subsequently used for analysis of propranolol in human
serum samples in a 96-well plate radio-labeled MIA, which
was effective in determining propranolol concentration be-
tween 1 mM and 1 μM.
Following these optimization studies, the use of radio-
labels in MIAs saw a huge decline as fluorescence- and
enzyme-labeling becamemore popular, for reasons previously
discussed. A rare example saw their use in the evaluation of a
molecularly imprinted polymer for the selective recognition of
testosterone [74]. Whilst previous efforts had been made to
synthesize testosterone-templated polymers [75–79], these
had failed to display impressive imprinting factors, the best
reported being around 4, making them unsuitable for an ap-
plication as an antibody mimic. This study aimed to improve
on this, with the intention of optimizing testosterone imprinted
MIPs in an aqueous environment for use in a radiolabeled
MIA. The imprinted polymers developed showed appreciable
binding affinity with association constants, Ka=3.3×10
7 M−1,
whilst the nonimprinted controls bound virtually no
radiolabeled testosterone, leading to a high imprinting factor
compared with those previously reported. When applied to a
radio assay in an aqueous environment, the molecularly
imprinted polymers achieved an IC50 of 9 μM, making them
less sensitive than commercial antibody kits; however, the
selectivity exhibited was higher for the MIPs.
Fluorescence-based MIAs
With the decline in use of radio-labeled tracers, a consequent
rise in fluorescent-labeled MIAs occurred. In a typical
fluorescence-labeled MIA, the target analyte is used as the
template during MIP generation, whilst a fluorescent probe
with similar structure is employed in competition with free
analyte for binding to the polymer during the assay. This al-
lows for sensitive and quantitative analysis through detection
of the fluorescence signal. Despite its advantages, fluorescent-
ly labeled MIAs are hindered somewhat by the necessity to
modify the target analyte in cases where there is no inherent
fluorescence, in order to detect a signal. This is usually
achieved through the addition of a fluorescent tag/group, mak-
ing the structure of the probe chemically different to the ana-
lyte. The fluorescent conjugate may therefore display different
binding behavior to the original analyte, which could impact
on the sensitivity and selectivity of the assay. Nevertheless,
impressive results have been achieved with this MIA format,
with some recent developments, such as the incorporation of
quantum dots, eliminating these problems entirely.
Heterogeneous fluorescent assays
Heterogeneous fluorescence-based assays are characterized
by the physical separation of bound and unbound analyte prior
to measuring the fluorescence intensity of the supernatant (or
polymer) in order to perform a quantitative analysis.
Modification with pyrene or dansyl moieties led to the
development of novel, highly fluorescent derivatives of the
β-lactam antibiotics [80]. These compounds were ideal for
optical sensing purposes and were, hence, employed in an
imprinted-polymer based competitive assay for penicillin G
(PenG) [81]. Selection of the most appropriate probe was con-
ducted using radio-labeled competitive assays, with
pyrenemethylacetamido penicillanic acid (PAAP) showing
the most promise from the candidate library. The resulting
fluorescence assay exhibited a dynamic range of 3–890 μM
in 99:1 acetonitrile-water solution, with reasonable degrees of
cross-reactivity (from 57 % to 0 %). When applied to the
analysis of PenG in a commercial pharmaceutical formulation,
recoveries from 92 % to 103 % were found. This assay was
later adapted to an automated flow-injection MIA system,
combining the simplicity of flow methods with the sensitivity
and selectivity of the fluorescence detection [82]. The analyte
and a fixed concentration of PAAP probe were injected into
the MIP-packed reactor, where competition for the binding
sites of the MIPs imprinted with penicillin G procaine salt
occurred. Following application of a desorbing solution, the
fluorescence of the labeled derivative eluted from the sorbent
was measured and related to the analyte concentration in the
sample. When applied to the direct analysis of PenG in spiked
urine samples, mean recoveries of 92 %were observed, over a
dynamic range from 787 nM to 17.1 μM. The total analysis
time was 14 min per determination, with the MIP reactor
capable of performing 150 cycles without significant loss of
recognition. Furthermore, use of novel urea-based functional
monomers in the MIP-synthesis facilitated compatibility of
the system with aqueous samples—a first for automated
MIAs.
Following the success of radio-labeledMIAs based onMIP
micro- and nanoparticles, controlled radical polymerization
was explored as a method for the synthesis of surface-
imprinted core-shell nanoparticles [83]. Surface reversible ad-
dition fragmentation chain transfer (RAFT) polymerization
was utilized on the surface of functionalized silica nanoparti-
cles in the presence of 2,4-dichlorophenoxyacetic acid as tem-
plate. The nanoparticles afforded by this process were subse-
quently applied to fluorescent-labeled MIAs using 7-carboxy-
4-methylcoumarin (CMMC) as fluorescent probe. Whilst the
nanoparticles generated showed no advantages over
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conventional irregular particles with regards to cross-reactiv-
ity, this new technology demonstrated a robust and controlla-
ble synthesis with more freedom for monomer/solvent
compositions.
Generally, the preparation of MIPs uses single-template
imprinting; however, reports ofMIPs containingmultiple sites
with the ability to recognize two or even three molecules are
known [84–86]. In an attempt to prepare a receptor model for
biological mixed neurotransmitter receptors, Suedee et al. syn-
thesized a dual dopamine/serotonin-selective MIP by bulk po-
lymerization using methacrylic acid and acrylamide as func-
t ional monomers, together with N ,N ′ -methylene
bisacrylamide as cross-linker in the presence of both tem-
plates, dopamine and serotonin [87]. This dual-MIP was used
in a competitive binding assay, where quantification was
achieved by using the native templates as fluorescent probes.
In this manner, the assay was used to attain the ligand binding
activities of a series of ergot family alkaloids, in order to assess
their ability to displace dopamine/serotonin from the MIP
binding sites. Results were comparable to those obtained from
a competitive immunoassay using receptors derived from rat
hypothalamus, demonstrating binding affinities in the micro-
molar or submicromolar range and showing that MIPs can be
capable of mimicking natural receptors in their interactions
with drug targets.
Homogeneous fluorescent assays
In contrast to heterogeneous assays, homogeneous assays al-
low direct analyte measurement without the need for a phys-
ical separation step; however, this does mean that a more
elaborate method for recognizing bound analyte as opposed
to unbound analyte is required.
With the intention of combing the principles of a homoge-
nous MIA and the use of a fluorescent probe, Hunt et al. de-
veloped a fluorescence polarization molecular imprinted sor-
bent assay for 2,4-D [88]. When the fluorescent probe, in this
case 7-carboxy-4-methylcoumarin, binds to a MIP in solution,
its tumbling rate falls and, consequently the measured fluores-
cence will be more isotropic than that of free probe, which
tumbles faster. The fluorescence polarization hence increases
with the percentage of probe bound, or decreases with the
amount of competing analyte. In order to perform fluorescence
measurements on a mixture of a fluorophore and polymer par-
ticles in solution, it was important that fluorescence could be
distinguished from the scattering of excitation light by the
polymer particles. This required the excitation and emission
wavelengths to be well separated, and the polymer particles to
be very small. Micrometer-sized particles, as previously, used
were therefore too large and, consequently, the paper demon-
strated for the first time that MIP microgels of diameter less
than 300 nm could indeed have affinities and selectivities sim-
ilar to those of bulk polymers. The limit of detection of the
assay was 10 μM for 2,4-D, while selectivity was shown for
the template molecule over the related herbicides 3,4-
dichlorophenoxy acid and 2,4-dichlorophenoxybutyric acid.
A similar MIA utilizing fluorescence polarization as an
analytical technique was also developed for the direct detec-
tion of fluoroquinolone antibiotics in food and environmental
samples [89]. As the fluoroquinolones of interest display in-
herent fluorescence, the need to integrate an additional probe
into the system was not necessary, unlike in the previous ex-
ample. Water-compatible MIP nanoparticles were synthesized
with enrofloxacin (ENRO) as the imprinting template; how-
ever, this also showed similar affinity towards ciprofloxacin
and norfloxacin. The assay was successfully applied to deter-
mine fluoroquinolones in real samples without any prior con-
centration step by simply adding a known amount of MIP,
with no interference from sample components observed. In
tap water, the limit of detection for ENRO was 0.1 nM using
5 μg mL−1 of MIP, whilst in milk, ENRO and danofloxacin,
whose maximum residue limits have been fixed at 0.28 μM
and 0.08 μM, respectively, could be selectively measured and
distinguished from other families of antibiotics.
Turner et al. incorporatedN-2-propenyl-(5-dimethylamino)-
1-naphthalene sulphonamide into imprinted polymer films as a
fluorescent indicator for the detection of nitroaromatic com-
pounds in the vapor phase [90]. Binding of the explosives
was detected within a few min as a quenching of fluorescence.
Enhancement of fluorescence upon binding template is less
common, but examples exist. Ivanova-Mitseva et al. prepared
nanoparticles by grafting to a dendrimer core simultaneously
m o d i f i e d w i t h d a n s y l a m i d e g r o u p s a n d a
dialkyldithiocarbamate ester (iniferter) [91]. The nanoparticles
produced showed a positive fluorescent response to the pres-
ence of the template (acetoguanamine) at nanomolar concen-
trations (LoD=3.0×10−8 M), which was selective over close
structural analogues. A similar Blight-up^ detection for amino
acid derivatives has been demonstrated with a urea-based func-
tional monomer designed to interact with the carboxylate anion
on the template [92]. The polymer showed enantioselective
binding of L-phenylalanine benzyl ester at micromolar
concentrations.
An interesting development in homogeneous fluorescence
MIAs came as a result of improvements in luminescent
nanomaterials. Incorporation of these materials was first dem-
onstrated by Zhao et al., who reported the rational and rapid
fabrication of quantum dot (QD)-MIP fluorescent nano-
spheres capable of recognizing diazinon in aqueous media
[93]. Based on energy transfer from the excitation of
ZnS:Mn2+ (donor) to the absorption of diazinon (acceptor),
the fluorescence of the QDs-MIP nanospheres was greatly
quenched as the template molecules rebound into the recog-
nition cavities (Fig. 3). The dramatic fluorescence quenching
could be applied to the direct and selective fluorescence quan-
tification of diazinon in aqueous media, with the developed
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assay displaying a linear relationship over the concentration
range 50–600 ng mL−1. As a proof of concept, the QDs-MIP
nanospheres were applied to the analysis of diazinon in tap
water samples spiked with 200 ng mL−1 of the analyte, with
excellent recoveries varying from 98.2 % to 105.4 %, demon-
strating the applicability to detection in real environmental
water samples without any pretreatment.
Incorporation of QDs as a source of fluorescence signaling
was also the method of choice adopted by Lee et al. during
development of the first MIP sandwich assay [94]. The sand-
wich fluoroimmunoassay was designed to detect and quantify
digestive proteins in saliva, utilizing quantum dots incorporat-
ed in protein imprinted poly(ethylene-co-vinyl alcohol)
(pEVAL) as a fluorescent signal (Fig. 4). The same polymer
(pEVAL) was also used as an imprinted thin film to coat mi-
croplate wells as a replacement for primary antibodies in the
sandwich assay system. The system relies on the random im-
printing of different surface features of the target protein
(epitopes) in the primary and secondary polymer components,
similar to that obtained with polyclonal antibodies. When ap-
plied to measurements of saliva samples, the recovery accura-
cy attained by this method was ±20 %–25 %, whilst the linear
range for amylase, lipase, and lysozyme stock solution were
0.1–10 ng mL−1, with the limit of detection as low as
1 pg mL−1. These results therefore represented the most sen-
sitive detection yet achieved with MIPs.
Enzyme-linked MIAs
The use of enzyme-labeling analytes was first implemented as
early as 1968, and has since become the most popular method
for labeling in immunoassays. This trend has translated over
to MIAs also, as traditional problems of incompatibility with
water and accessibility of binding sites with the use of en-
zymes with MIPs have been overcome. Enzyme-labels still
suffer the same problems as fluorescent probes with regards
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to conjugation of the label to the analyte and the effect this
consequently has on the recognition and binding of the labeled
analogue; however, the commercial availability of many en-
zymes at low cost and general ease of conjugation offer sig-
nificant advantages. Additionally, many enzyme labels under-
go simple colorimetric/fluorimetric reactions during their ap-
plication, requiring detection devices no more complex or
expensive than a multichannel colorimetric/fluorimetric
reader.
The aforementioned difficulty of binding site availability
has led to adoption of in situ polymerization of imprinted films
on the surface of 96-well plates as the most popular technique
for development of biomimetic ELISA-like assays (Table 1).
By utilizing a film format, a large surface area can be
achieved, whilst control of the film thickness assists in access
to binding sites. The method has been used extensively for a
variety of templates, with the developed assays being applica-
ble to determination of their respective analytes in environ-
mental water samples [95, 96], soil [96], pork [97], urine [97,
98], vegetables [99], chick feed [100], sea cucumber [101],
French fries, and crackers [102].
Recent work reported by Shi et al. describes the devel-
opment of a MIP-based ELISA for simultaneous multi-
pes t ic ide ana lys i s [103] . The chosen templa te ,
4-(dimethoxyphosphorothioylamino)butanoic acid, had
been shown to share a common structure and functional
groups with organophosphorus pesticides, and so the intention
was that this template could be used to produce a MIP with
recognition for the organophosphorus class of compounds,
rather than just the template. The imprinted film proved to
be effective for selectively recognising trichlorfon and
acephate, with an IC50 of 12.0 mg L
−1 and 30.0 mg L−1 for
each analyte, respectively. Overall, the assay showed linearity
from 0.1 to 100,000 μg L−1, making it suitable for the desired
purpose of determining trace amounts of pesticides in food
samples. When subjected to spiked asparagus and cucumber
samples, recoveries from 72.1 % to 92.0 % for trichlorfon and
70.0 % to 85.0 % for acephate were achieved.
An interesting variation on surface-imprinting was per-
formed in order to achieve the first 96-well microplate MIP
ELISA for glycoprotein detection and quantification [104]. In
this work, a 96-well microplate was functionalized with a
common boronic acid at the well surface, allowing a target
glycoprotein to be immobilized by virtue of boronate affinity.
Following this, a hydrophilic coating formed by in-water self-
copolymerization of aniline was deposited onto the well sur-
face, affording a 3D cavity complementary to the molecular
shape of the target following removal with acid (Fig. 5). The
group prepared α-fetoprotein (AFP)-imprinted microplates to
develop a MIP-based sandwich ELISA, which showed good
linearity over the range 0–50 ng mL−1. When applied to a
human serum sample, the AFP concentration was determined
to be 12±2.0 ng mL−1, which was in good agreement with the
value determined by radioimmunoassay (10 ng mL−1), show-
ing a promising prospect of the proposed method in clinical
diagnostics.
Although impressive results have been achieved using
molecularly imprinted films, attempts to improve upon this
method have been made. With regards to the films used in
these assays, their resemblance to polyclonal antibodies gave
rise to high levels of nonspecific binding, whilst their manu-
facture relied onmanual, labor intensive methods of synthesis.
The assays themselves utilized complex immobilization pro-
tocols and lacked generality, requiring substantial modifica-
tion to the analytical procedures traditionally used in ELISA.
Table 1 Recent examples of MIAs utilising enzyme-labels and in situ








Estrone 0.50–50,000 200±40 8.0±0.2 [92]
Ractopamine 0.01–1000 15.8±3.2 0.01 [97]
Methimazole 0.60–60,000 70.0±4.0 0.9±0.04 [98]
Trichlorfon 3.20–50,000 6800±60 6.8±0.2 [99]
Olaquindox 17.0–50,000 700±60 17±1.6 [100]
Chloramphenicol 0.30–30,000 30.0±2.0 0.9±0.01 [101]
Tribenuron-methyl 0.10–10,000 19.7±1.2 0.3 [96]
Acrylamide 16.0–50,000 8000±0.4 85±4.2 [102]
Fig. 5 Sandwich ELISA for α-fetoprotein (AFP) following boronate
affinity-based oriented surface imprinting [104]. Reprinted with
permission from Bi X, Liu Z (2014) Analytical Chemistry 86(1):959–
966. Copyright 2014 American Chemical Society
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In an attempt to resolve some of these problems, Poma et al.
developed a method for solid-phase synthesis of MIP nano-
particles with pseudomonoclonal binding properties suitable
for automation in a computer-controlled reactor [105]. To
demonstrate the potential of materials prepared in this manner,
a novel assay for vancomycin directly replacing antibodies
with molecularly imprinted polymer nanoparticles in ELISA
was proposed [106]. In order to utilize previously synthesized
MIP nanoparticles, a simple and straightforward technique for
coating microplate wells was required. This was achieved
through physical adsorption by allowing a solution of
nanoMIPs to evaporate to dryness within each of the micro-
plate wells, removing the necessity for a complex immobili-
zation method or in situ formation of the imprinted material
through polymerization in the test wells. Following immobi-
lization, the nanoMIPs could be used in competitive binding
experiments between free and HRP-labeled vancomycin
(Fig. 6). The assay was capable of measuring vancomycin in
buffer and in blood plasma within the range of 0.001–70 nM,
a sensitivity three orders of magnitude better than a previously
described ELISA based on antibodies. The generic nature of
nanoMIP preparation by solid-phase synthesis suggests that
assays for many more analytes may also be created in this
manner.
Other MIA formats
Although the majority of molecularly imprinted assays fall
into the previously discussed categories, several novel assay
types have been developed utilizing the unique properties of
MIPs.
Taking advantage of the swelling/deswelling behavior of
hydrogels, Hu et al. developed an ultrasensitive specific stim-
ulant assay based on molecularly imprinted photonic
hydrogels [107]. In this work, colloidal crystals and molecular
imprinting were combined to prepare imprinted photonic
polymers (IPP) with three-dimensional, highly-ordered,
macroporous structures, which could be used to optically de-
termine analytes by means of the shift of the Bragg diffraction
attributable to a change of the periodic lattice spacing. The IPP
hydrogels swell in response to chemical stimuli, giving rise to
a visually perceptible color change, which can easily be im-
plemented into a rapid and sensitive assay (Fig. 7). IPP-
hydrogel films against theophylline and (1R,2S)-(−)-ephed-
rine both exhibited high sensitivity and selectivity, enabling
the quantification of as low as 0.1 fM. concentration of analyte
even in a competitive urinous buffer. Similar detection
methods have been demonstrated in colloidal crystal and in-
verse opal configurations. Although many of these have been
described as sensors, rather than assays, they are worthy of
mention since they operate in the same manner. Analytes de-
termined in this fashion include bisphenol A [108, 109], or-
ganophosphorus compounds [110], imidacloprid [111], glu-
cose [112], amino acids [113], progesterone [114], tetracycline
[115], and 17β-estradiol [116]. Volume changes have also
been employed in the detection of proteins in hydrogels
imprinted using novel functional monomers based on
aptamers [117]. In this work, the protein thrombin was used
as the template with two distinct polymerizable aptamer se-
quences as functional monomers chosen to bind to different
regions of the protein surface. After template removal the
hydrogel could be used to detect protein binding by changes
in the macroscopic dimensions (shrinkage) of the gel down to
femtomolar concentrations (Fig. 8).
Similarly to fluorescence, chemiluminescence has also
been employed as a signaling method for MIAs. An assay
for dipyridamole has been developed utilizing light emitted
from dipyridamole peroxyoxalate chemiluminescence (PO-
CL) reaction as a means of detection [118]. MIP microspheres
of 0.7 μm diameter were prepared using precipitation
Fig. 6 ELISA utilizing
nanoMIPs synthesized using a
solid phase protocol [106].
Reprinted (adapted) with
permission from Chianella I,
Guerreiro A, Moczko E, Caygill
JS, Piletska EV, De Vargas
Sansalvador IMP, Whitcombe
MJ, Piletsky SA (2013)
Analytical Chemistry
85(17):8462–8468. Copyright
2013 American Chemical Society
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polymerization with methacrylic acid as functional monomer
and trimethylolpropane trimethacrylate as cross-linker in the
presence of dipyridamole, with poly(vinyl alcohol) utilized to
immobilize the imprinted polymers to the walls of 96-
microtiter well plates. Following sample incubation, the
amount of polymer-bound dipyridamole was determined
using a high-resolution charge coupled device camera to mea-
sure the light emitted from the PO-CL reaction. Under optimal
conditions, the relative chemiluminescence imaging intensity
was proportional to dipyridamole concentration from 0.02 to
10 μg mL−1, with the assay format able to perform 96 inde-
pendent measurements simultaneously in 30 min.
A molecularly imprinted polymer-based lab-on-paper
chemiluminescence device for the detection of dichlorvos
(DDV) was reported by Liu et al., generating chemilumines-
cence signals following reaction of DDV, luminol, and H2O2
in alkaline medium, allowing for a powerful and sensitive tool
for selective monitoring of DDV [119]. The MIP layer was
adsorbed onto the paper surface, whilst the depth was
controlled at 600 μm by stacking glass slides with double-
sided tape of 600 μm depth (Fig. 9). When applied to vegeta-
ble samples, the device was effective from 3.0 ng mL−1 to
1.0 μg mL−1 with a detection limit of 0.8 ng mL−1. Whilst
the work demonstrates the promise of chemiluminescence-
based detection for paper microfluidic chips, the adaptability
of this device to the analysis of other analytes could be limited,
as they, like DDV, would be required to elicit a chemilumi-
nescence signal following addition of luminol/H2O2.
Although the replacement of antibodies with synthetic
mimics has been the focus of biomimetic ELISA-like assays,
the added advantages (mainly storage/thermal stability and
low cost) afforded by use of these materials is not effectively
exploited if the assay system still requires the use of a biolog-
ical reporter enzyme. In an attempt to rectify this, Shutov et al.
reported the integration of catalytically active Fe3O4 with mo-
lecularly imprinted nanoparticles (MINs) as combined recog-
nition and signaling functionalities in a core-shell nanoparticle
format to develop the first ELISA-like assay (MINA) to
Fig. 7 Schematic illustration of
the created imprinted photonic
polymers (IPP) structure and the
color change as a result of
swelling/deswelling following
rebinding or extraction of analyte
[107]. Reproduced with
permission from: Ultrasensitive
Specific Stimulant Assay Based
on Molecularly Imprinted
Photonic Hydrogels, Hu XB, Li
GT, Li MH, Huang J, Li Y, Gao
YB, Zhang YH. Advanced
Functional Materials, Vol. 18:4,
Copyright © 2008, John Wiley
and Sons
Fig. 8 Aptamer-based hydrogels imprinted with thrombin that show
macroscopic changes in dimension on binding the target protein down
to femtomolar concentration [117]. Reprinted with permission from Bai
W, Gariano NA, Spivak DA (2013) Journal of the American Chemical
Society 135(18):6977–6984. Copyright 2013 American Chemical
Society
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completely replace all biologics with synthetic analogues
[120]. The intrinsic peroxidase mimicking activity of Fe3O4
nanoparticles makes them attractive substitutes for enzymes in
a variety of assays, with suitable catalytic activity over a broad
range of temperatures, low cost/long shelf life, and ease of
manufacture. A variation of the solid-phase imprinting proto-
col was utilized to produce the composite core-shell Fe3O4-
MIN, using vancomycin as template (Fig. 10). Subsequent
magnetic separation ensured that only high-affinity nanopar-
ticles containing the catalytic Fe3O4 core were recovered from
the process. By immobilizing the template (vancomycin) to
the surface of well plates, a competitive assay could be per-
formed using the previously synthesized core-shell nanoparti-
cles, with quantification made possible through the oxidation
of 3,3′,5,5′-tetramethylbenzidine (TMB) to give a colorimetric
response proportional to the quantity of Fe3O4 catalyst bound
to the template. The developed assay was effective over the
range of 10 nM to 1 mM, retaining applicability even in com-
plex sample matrices such as porcine serum, although this did
require use of a spacer between immobilized vancomycin and
the well surface.
A number of sandwich-type assays have been developed,
achieving incredible sensitivity surpassing that of other previ-
ously mentioned methods. A new approach, termed the
boronate-affinity sandwich assay (BASA), was applied for
the specific and sensitive determination of trace glycoproteins
in complex samples [121]. The technique relies on the forma-
tion of sandwiches between boronate-affinity molecularly
imprinted polymers, target glycoproteins, and boronate-
affinity surface-enhanced Raman scattering (SERS) probes
(Fig. 11). In this way, the MIP ensures the specificity, whilst
the SERS detection provides sensitivity. The feasibility of the
BASA approach for real-world applications was demonstrated
by an assay of the glycoproteinα-fetoprotein in human serum.
The MIP array exhibited a linear response toward AFP within
the range of 1 ng mL−1 to 10 μg mL−1, and was able to
determine the analyte concentration in good agreement with
results from other methods (13.8±3.3 ngmL−1 compared with
12.0±2.0 ng mL−1).
A further novel sandwich-type immunoassay for simul-
taneous determination of AFP and carcinoembryonic anti-
gen (CEA) using graphene–Au grafted recombinant
apoferritin-encoded metallic labels (rApo-M) loaded with
Cd and Pb ions with dual-template magnetic MIPs
(MMIPs) as capture probes was designed by Wang et al.
[122]. After a sandwich-type immunoreaction, the labels
were captured at the surface of MMIPs, allowing electro-
chemical stripping analysis of the metal components from
the immunocomplex to provide a means of quantification
based on the peak currents of Cd and Pb (Fig. 12).
Experimental results showed that the assay could simulta-
neously detect AFP and CEA in a single run with a dynam-
ic range of 0.001–5 ng mL−1. The possibility to expand the
number of analytes for simultaneous analysis by
implementing more rApo nanoparticles (including Pb,
Cd, Cu, and Zn) as distinguishable labels shows promising
potential for this approach in clinical detection of
multianalytes.
Fig. 9 The procedure used to
prepare MIP on paper [119].
Reprinted from Spectrochimica
Acta Part A: Molecular and
Biomolecular Spectroscopy, Liu
W, Guo YM, Luo J, Kou J, Zheng
HY, Li BX, Zhang ZJ. A
molecularly imprinted polymer
based a lab-on-paper
chemiluminescence device for the
detection of dichlorvos, 141:51–
57. Copyright 2015, with
permission from Elsevier
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By taking advantage of the inherent chemical properties of
chloramphenicol (CAP), a portable and antibody-free sand-
wich assay for determination of chloramphenicol in food
based on a personal glucose meter was developed by Chen
et al. [123]. The assay utilized polydopamine molecularly
imprinted film modified Fe3O4 nanoparticles and a β-
cyclodextrin (β-CD)/invertase bioconjugate for recognition
and subsequent glucose generation. A fragment imprinting
technique was adopted for the synthesis of the polymer film,
in which 2,2-dichloroacetamide was used as template. This
enabled affinity for a section of CAP resembling the used
template, without interfering with the nitrophenol fragment
in CAP. β-Cyclodextrin is known to combine with nitrophe-
nol to form a host–guest complex by means of the hydropho-
bic cavity, and so this exposed region following MIP binding
could be utilized for attachment of a β-CD-based signal tag to
form a sandwich-type complex for CAP detection. Invertase
was selected for conjugation toβ-CD, where it could facilitate
Fig. 10 Schematic of the
solid-phase synthesis protocol
with addition of Fe3O4 for
preparation of peroxidase-
mimicking core-shell MIN
(top left) and TEM image of the
obtained Fe3O4-MIN particles
(top right). The assay format
(bottom left) and calibration curve
(bottom right) are also shown
[120]. Reproduced with
permission from: Introducing
MINA - The Molecularly
Imprinted Nanoparticle Assay.
Shutov RV, Guerreiro A, Moczko
E, de Vargas-Sansalvador IP,
Chianella I, Whitcombe MJ,
Piletsky SA, Small, Vol. 10:6.
Copyright © 2014 John Wiley
and Sons
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the generation of glucose from sucrose to elicit a measurable
response using a personal glucose meter (Fig. 13). Using this
method, the concentration of CAP was found to be propor-
tional to the amount of glucose formed, which could qualita-
tively assess the CAP with a dynamic range of 0.5–
50 ng mL−1 and a detection limit of 0.16 ng mL−1. Although
an elegant strategy, there is great dependence on the structure
of the analyte for this method to be applicable because of the
need for a nitrophenol moiety to facilitate β-CD complexa-
tion, and so the number of substrates able to be analyzed in
this manner is limited.
Binding of analytes to the specific recognition sites of
imprinted polymers results in a change in the heat-transfer
resistance of the materials, which can be used as a sensing
or assay technique for their detection. The method (heat-
transfer method) has been used as a means of quantifying a
Fig. 11 Schematic representation of the boronate-affinity sandwich assay
of glycoproteins [121]. Reproduced with permission from: A Boronate
Affinity Sandwich Assay: An Appealing Alternative to Immunoassays
for the Determination of Glycoproteins, Ye J, Chen Y, Liu Z (2014)
Angewandte Chemie International Edition, Vol. 53:39. Copyright ©
2014, John Wiley and Sons
Fig. 12 Schematic representation of simultaneous electrochemical
immunoassay. (A) preparation of signal tags: (a) in situ reducing
HAuCl4 onto graphene (G) to form G–Au; (b) immobilization of labels
(rApo-M); (c) labeling with anti-AFP and anti-CEA and blocking of
excess active sites with BSA (1.0 wt% ). (B) synthesis of the capture
probes and electrochemical detection: (a) polymerization of DA to form
a PDA coating on Fe3O4 in the presence of template proteins; (b) Eluting
with SDS to remove embedded template proteins and obtain MMIP; (c)
recognition with targets analytes (AFP and CEA); (d) blocking with
BSA; (e) antigen–antibody specific reaction with above signal tags; (f)
magnetic separation and electrochemical detecting with SWV [122].
Reprinted from Biosensors and Bioelectronics. Wang D, Gan N, Zhang
HR, Li TH, Qiao L, Cao YT, Su XR, Jiang S. Simultaneous
electrochemical immunoassay using graphene–Au grafted recombinant
apoferritin-encoded metallic labels as signal tags and dual-template
magnetic molecular imprinted polymer as capture probes, 65:78–82.
Copyright 2015, with permission from Elsevier
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range of analytes, including l-nicotine, histamine, and seroto-
nin [124, 125] and mammalian cells, including cancer cells
[125–128]. The method is sensitive, does not require labels,
and is compatible with biological entities.
Prospects for diagnostic applications
The motivation for developing assays employing MIPs in
place of antibodies has been the advantages that these ma-
terials would bring to the field. Generally, MIP develop-
ment is shorter and less expensive than antibody develop-
ment, targets do not require conjugation to immunogenic
proteins, experimental animals are not involved in the pro-
cess, and MIPs do not require cold storage and cold-chain
logistics. Barriers to adoption of these new technologies
may be uncertainty over security of supply and the percep-
tion that changes need to be made in manufacturing prac-
tices and plant in order to make the switch from antibodies
to MIPs. This need not be the case, however, as several
groups have demonstrated assays with nanoMIPs that have
been used as direct replacements for antibodies in a num-
ber of assay formats.
In the medical diagnostics area, there is always concern
about the possibility of false positives and false negatives in
any diagnostic test. The former can lead to misdiagnosis and
inappropriate treatment and the latter to the failure to diagnose
a potentially life-threatening condition. It should not be for-
gotten, however, that these concerns also apply to antibody-
based tests and, indeed, to any technology used in diagnosis
based on molecular recognition. The implication is that new
methods should be validated against existing tests and
Fig. 13 a Preparation of magnetic molecularly imprinted polymers. b
EnVision reagent (EV)-Au-β-cyclodextrin/invertase signal tag
preparation. c Scheme for the sandwich assay [123]. With permission
from Springer Science+Business Media: Analytical and Bioanalytical
Chemistry. A portable and antibody-free sandwich assay for
determination of chloramphenicol in food based on a personal glucose
meter, 407:2499–2507. Chen S, Gan N, ZhangHR, Hu FT, Li TH, Cui H,
Cao YT, Jiang QL (2015) Fig. 1. Copyright 2015, with permission from
Elsevier
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analytical procedures that use more robust methods (such as
LC-MS-MS) that provide unambiguous identification and
quantitation of the analyte. More studies in this vein would
certainly support the case for the adoption of MIPs by the
diagnostic industry.
Many biomarkers for disease diagnosis and monitoring
are peptides and proteins. Reports of protein imprinting in
the literature have greatly increased in recent years; how-
ever, proteins are difficult templates to work with and not
all reports provide strong evidence for imprinting. Kryscio
et al. have shown that the structure of proteins typically
employed as templates are adversely affected by exposure
to monomers and cross-linkers commonly used in imprint-
ing [129, 130]. Verheyen and co-workers have also
highlighted the problems of nonspecific interactions with
polymers carrying charged monomers, which can over-
whelm specific binding to MIPs; they also point out the
dangers of template removal using SDS and acetic acid,
which has led to a number of misleading results [131].
They argue that high binding affinity for proteins can only
arise with a combination of hydrogen-bonding, electrostat-
ic and hydrophobic interactions in the correct balance.
These and other issues have been raised in other reviews
[132, 133], which recommend that surface imprinting ap-
proaches be employed with whole protein templates to
avoid entrapment and poor binding kinetics. They also
point out that Bepitope^ imprinting [134] avoids many of
the pitfalls associated with imprinting macromolecules, as
long as the nonspecific binding issue is addressed.
Conclusions and future prospects
During the last decade, significant progress has been made
with regards to molecularly imprinted sorbent assays. Many
of the problems that inhibited the growth of the area have been
resolved following improvements in synthetic methods and a
greater understanding of the molecular imprinting process,
with fluorescent and enzyme-linked MIAs now common-
place. Recent years have seen a move away from traditional
Bbulk^ MIP synthesis in favor of particle-based syntheses; in
particular, MIP nanoparticles hold great promise as they are
more easily incorporated into existing assays formats.
Composite architectures with other nanomaterials (such as
quantum dots, gold nanoparticles, carbon nanotubes, and
graphene) may provide novel detection mechanisms and
higher sensitivity. MIPs grafted to the surface of microplate
wells hold promise but are unlikely to be adopted by industry
because of manufacturing difficulties. Of particular interest
are homogeneous assays that do not require separation steps
since they simplify analysis and reduce the possibility of er-
rors in measurement. In terms of read-out, colorimetric
methods require the simplest instrumentation, which could
be a hand-held colorimeter or, in some cases, a simple color
chart might suffice. Other read-out methods such as fluores-
cence detection may require more sophisticated or expensive
instruments suitable for the general practitioner’s office or
hospital laboratory. None of these considerations differ very
much from antibody-based tests, and the storage requirements
for MIPs are less demanding.
Challenges still remain to be overcome; the lack of gen-
erality amongst assay formats and development is a dis-
couraging factor against the adoption of MIAs over con-
ventional immunoassays. The dawn of automated MIP-
nanoparticle synthesizers and solid-phase selection pro-
cesses to isolate only high-quality MIPs shows great prom-
ise for the development of a universal strategy for assay
generation, if these technologies manage to live up to their
potential.
Interest continues to grow in the field of molecular im-
printing technology as evidenced by the constantly
expanding quantity of literature on the subject, indicating
a bright future for the development of molecularly
imprinted sorbent assays.
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